Purilax Dermal Filler — Aeterderm SMART-Crosslink™ Technology — 1.1ml
- Aeterderm SMART-Crosslink™ Technology
- Concentration-graded: Fine 20 / Deep 24 / Sub-Q 28 mg/mL
- Ultra-low endotoxin <0.025 EU/mL
- For licensed professionals only
| 1 - 4 boxes | $27.40 / box |
| 5 - 9 boxes | $26.30 / box |
| 10 - 19 boxes | $25.21 / box |
| 20+ boxes | $24.66 / box |
What Is Purilax Dermal Filler — Aeterderm SMART-Crosslink™ Technology — 1.1ml?
**Purilax** is a three-variant Korean HA dermal filler series manufactured by Aeterderm / Wederm Co., utilizing SMART-Crosslink™ technology to deliver concentration-graded hyaluronic acid (Fine 20 mg/mL, Deep 24 mg/mL, Sub-Q 28 mg/mL) with 0.3% lidocaine, ultra-low endotoxin (<0.025 EU/mL), and high G' viscoelastic retention for professional facial contouring and wrinkle correction.
Purilax stands apart from conventional HA filler series by offering concentration-graded variants rather than simple cross-linking differentiation. Each of the three variants — Fine (20 mg/mL), Deep (24 mg/mL), and Sub-Q (28 mg/mL) — is formulated with a distinct HA density matched to its target dermal depth, delivering optimized viscoelasticity at every level from superficial dermis to deep subcutaneous placement. SMART-Crosslink™ technology ensures ultra-low endotoxin levels below 0.025 EU/mL with minimal BDDE residue, with results lasting 12–18 months.
Specifications
| Product name | Purilax Dermal Filler — SMART-Crosslink™ Technology |
|---|---|
| Active ingredient | Cross-linked HA (20/24/28 mg/mL per variant) + Lidocaine 0.3% |
| Volume | 1 × 1.1ml pre-filled syringe |
| Endotoxin level | <0.025 EU/mL |
| Gel structure | Monophasic |
| Technology | SMART-Crosslink™ (low-BDDE) |
| HA Source | Bacterial fermentation, non-animal origin |
| Application | Mid-dermal to subcutaneous per variant |
| Treatment areas | Fine lines, periorbital, lips, NLF, marionettes, cheeks, chin, jawline, body contour |
| Origin | South Korea (Aeterderm / Wederm Co.) |
| Storage | 2–25°C, do not freeze, protect from direct sunlight |
| Shelf life | 24 months unopened |
Key Benefits
- Concentration-graded variants (20/24/28 mg/mL) deliver optimized HA density matched to each dermal depth
- SMART-Crosslink™ technology achieves ultra-low endotoxin (<0.025 EU/mL) for exceptional biocompatibility
- Three viscoelasticity tiers cover every treatment zone from superficial lines to deep structural volumization
- High G' viscoelastic retention provides durable results lasting 12–18 months
- Room-temperature stable storage (2–25°C) simplifies inventory management
Suggested Treatment Protocol
Treatment protocol varies by variant. Purilax Fine is injected into the mid dermis using a 30G needle for fine lines, periorbital wrinkles, and lip border definition. Purilax Deep targets the mid-to-deep dermis using a 27G needle for nasolabial folds, marionette lines, and lip body. Purilax Sub-Q is placed in the subcutaneous plane for cheek and chin volumization, jawline contouring, and body contouring. A full treatment plan of 1–3 sessions with 4–8 week intervals is recommended. The exact injection depth, volume, and treatment schedule should be determined by the treating practitioner based on individual patient anatomy and aesthetic goals.
Frequently Asked Questions
What is Purilax dermal filler?
Purilax is a monophasic hyaluronic acid dermal filler series using SMART-Crosslink™ technology, available in three concentration-graded variants — Fine, Deep and Sub-Q — for professional facial contouring and wrinkle correction.
What is the difference between the Fine, Deep and Sub-Q variants?
The three variants use concentration-graded HA density matched to different dermal depths: Fine (20 mg/mL) is injected into the mid dermis for fine lines and periorbital wrinkles; Deep (24 mg/mL) targets the mid-to-deep dermis for nasolabial folds and marionette lines; Sub-Q (28 mg/mL) is placed in the subcutaneous plane for cheek, chin and jawline volumization.
What is the HA concentration and how is Purilax supplied?
Purilax contains cross-linked hyaluronic acid (20/24/28 mg/mL per variant) with 0.3% lidocaine, supplied in 1 × 1.1ml pre-filled syringes. All variants feature ultra-low endotoxin levels below 0.025 EU/mL and high G' viscoelasticity, with results lasting 12–18 months.
How should Purilax be stored?
Store at 2–25°C, do not freeze, and protect from direct sunlight. Shelf life is 24 months unopened.
Do you offer wholesale pricing on Purilax?
Yes. Cytollia supplies Purilax at tiered wholesale prices for licensed clinics and distributors, with volume discounts on larger orders.
Fast delivery and good communication. Product matches the description. Happy with the purchase.
The 0.3%% lidocaine is a real plus — our patients report noticeably less discomfort during injection compared to the non-lidocaine brands we used before.
The 1.1ml syringe format is convenient for our clinic workflow. Less waste compared to the 1.5ml syringes we used to buy.
Please log in to leave a review.
